Literature DB >> 18802630

Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B.

Shahar Keinan1, William D Paquette, John J Skoko, David N Beratan, Weitao Yang, Sunita Shinde, Paul A Johnston, John S Lazo, Peter Wipf.   

Abstract

Quinoid inhibitors of Cdc25B were designed based on the Linear Combination of Atomic Potentials (LCAP) methodology. In contrast to a published hypothesis, the biological activities and hydrogen peroxide generation in reducing media of three synthetic models did not correlate with the quinone half-wave potential, E(1/2).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802630      PMCID: PMC2752828          DOI: 10.1039/b806712k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  28 in total

1.  Designing molecules with optimal properties using the linear combination of atomic potentials approach in an AM1 semiempirical framework.

Authors:  Shahar Keinan; Xiangqian Hu; David N Beratan; Weitao Yang
Journal:  J Phys Chem A       Date:  2007-01-11       Impact factor: 2.781

2.  Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.

Authors:  John S Lazo; Kaoru Nemoto; Katharine E Pestell; Kathleen Cooley; Eileen C Southwick; Douglas A Mitchell; William Furey; Rick Gussio; Daniel W Zaharevitz; Beomjun Joo; Peter Wipf
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

3.  Independent mechanistic inhibition of cdc25 phosphatases by a natural product caulibugulone.

Authors:  Marni Brisson; Caleb Foster; Peter Wipf; Beomjun Joo; Robert J Tomko; Theresa Nguyen; John S Lazo
Journal:  Mol Pharmacol       Date:  2006-10-03       Impact factor: 4.436

Review 4.  Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia.

Authors:  P Wardman
Journal:  Curr Med Chem       Date:  2001-06       Impact factor: 4.530

Review 5.  Redox regulation of the Cdc25 phosphatases.

Authors:  Johannes Rudolph
Journal:  Antioxid Redox Signal       Date:  2005 May-Jun       Impact factor: 8.401

6.  On benzo[b][1,4]diazepinium-olates, -thiolates and -carboxylates as anti-Hückel mesomeric betaines.

Authors:  Andreas Schmidt; Abbas Gholipour Shilabin; Martin Nieger
Journal:  Org Biomol Chem       Date:  2003-10-20       Impact factor: 3.876

7.  Inverse molecular design in a tight-binding framework.

Authors:  Dequan Xiao; Weitao Yang; David N Beratan
Journal:  J Chem Phys       Date:  2008-07-28       Impact factor: 3.488

Review 8.  Targeting mitochondria.

Authors:  Adam T Hoye; Jennifer E Davoren; Peter Wipf; Mitchell P Fink; Valerian E Kagan
Journal:  Acc Chem Res       Date:  2008-01       Impact factor: 22.384

9.  CDC25 phosphatases as potential human oncogenes.

Authors:  K Galaktionov; A K Lee; J Eckstein; G Draetta; J Meckler; M Loda; D Beach
Journal:  Science       Date:  1995-09-15       Impact factor: 47.728

10.  A gradient-directed Monte Carlo approach to molecular design.

Authors:  Xiangqian Hu; David N Beratan; Weitao Yang
Journal:  J Chem Phys       Date:  2008-08-14       Impact factor: 3.488

View more
  10 in total

Review 1.  Redox cycling compounds generate H2O2 in HTS buffers containing strong reducing reagents--real hits or promiscuous artifacts?

Authors:  Paul A Johnston
Journal:  Curr Opin Chem Biol       Date:  2010-11-11       Impact factor: 8.822

Review 2.  A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors.

Authors:  Ahmed Bakr Abdelwahab; Eslam Reda El-Sawy; Atef G Hanna; Denyse Bagrel; Gilbert Kirsch
Journal:  Molecules       Date:  2022-04-07       Impact factor: 4.927

3.  Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.

Authors:  Paul A Johnston; Caleb A Foster; Marni Brisson Tierno; Tong Ying Shun; Sunita N Shinde; William D Paquette; Kay M Brummond; Peter Wipf; John S Lazo
Journal:  Assay Drug Dev Technol       Date:  2009-06       Impact factor: 1.738

4.  Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments.

Authors:  Karina M Soares; Nicole Blackmon; Tong Ying Shun; Sunita N Shinde; Harold K Takyi; Peter Wipf; John S Lazo; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

5.  Reducing agents affect inhibitory activities of compounds: results from multiple drug targets.

Authors:  Hyun Lee; Jaime Torres; Lena Truong; Rima Chaudhuri; Anuradha Mittal; Michael E Johnson
Journal:  Anal Biochem       Date:  2012-01-18       Impact factor: 3.365

Review 6.  Recent advances in the transition-metal-free synthesis of quinoxalines.

Authors:  Biplob Borah; L Raju Chowhan
Journal:  RSC Adv       Date:  2021-11-19       Impact factor: 4.036

7.  In Vitro and In Silico Study to Assess Toxic Mechanisms of Hybrid Molecules of Quinone-Benzocaine as Plastoquinone Analogues in Breast Cancer Cells.

Authors:  Ayse Mine Yilmaz Goler; Ayse Tarbin Jannuzzi; Nilüfer Bayrak; Mahmut Yıldız; Hatice Yıldırım; Masami Otsuka; Mikako Fujita; Mohamed O Radwan; Amaç Fatih TuYuN
Journal:  ACS Omega       Date:  2022-08-15

8.  Natural-product-inspired design and synthesis of thiolated coenzyme Q analogs as promising agents against Gram-positive bacterial strains: insights into structure-activity relationship, activity profile, mode of action, and molecular docking.

Authors:  Hatice Yıldırım; Mahmut Yıldız; Nilüfer Bayrak; Emel Mataracı-Kara; Berna Özbek-Çelik; Masami Otsuka; Mikako Fujita; Mohamed O Radwan; Amaç Fatih TuYuN
Journal:  RSC Adv       Date:  2022-07-15       Impact factor: 4.036

9.  Mitochondrial targeted β-lapachone induces mitochondrial dysfunction and catastrophic vacuolization in cancer cells.

Authors:  Jing Ma; Chaemin Lim; Joshua R Sacher; Bennett Van Houten; Wei Qian; Peter Wipf
Journal:  Bioorg Med Chem Lett       Date:  2015-06-26       Impact factor: 2.940

10.  Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2.

Authors:  Rena G Lapidus; Brandon A Carter-Cooper; Mariola Sadowska; Eun Yong Choi; Omasiri Wonodi; Nidal Muvarak; Karthika Natarajan; Lakshmi S Pidugu; Anil Jaiswal; Eric A Toth; Feyruz V Rassool; Arash Etemadi; Edward A Sausville; Maria R Baer; Ashkan Emadi
Journal:  Pharmaceuticals (Basel)       Date:  2016-01-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.